Results 321 to 330 of about 179,498 (360)

γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

Cancer Cell, 2019
Imran Siddiqui, Anja Irmisch, Maxime Danilo   +2 more
exaly  

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

Nature, 2015
T. Pemovska, Eric Johnson, M. Kontro, G. Repasky, Jeffrey H. Chen, P. Wells, C. Cronin, M. McTigue, O. Kallioniemi, K. Porkka, B. Murray, K. Wennerberg   +11 more
semanticscholar   +1 more source

Signal Transducer and Activator of  Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis

Journal of Experimental Medicine, 1999
Mariusz A Wasik, Artur Slupianek, Paolo Salomoni   +2 more
exaly  

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients

Leukemia, 2010
Rocco Piazza, Sara Redaelli, Ilaria Iacobucci   +2 more
exaly  

Involvement of Jak2 tyrosine phosphorylation in Bcr–Abl transformation

Oncogene, 2001
Shanhai Xie, Thomas E Smithgall, Ralph B Arlinghaus   +2 more
exaly  

BCR

2011
openaire   +1 more source

Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia

Leukemia, 2010
A Samanta, Ravi Bhatia, Ralph Arlinghaus   +2 more
exaly  

Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia

Nature Reviews. Cancer, 2005
R. Ren
semanticscholar   +1 more source

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

British Journal of Cancer, 2006
Ellen Weisberg, Ray A
exaly  

BCR

2006
openaire   +1 more source